Skip to main content

Commodore Capital LP

SEC CIK
0001831942
Latest filing
Aug 14, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Commodore Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2023
Holdings of CRNX by Commodore Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−500,000−100.0%Sold outHolders
Q3 2023500,000$14.9M1.7%+500,000NewHolders